China still has ‘catching up to do’ to become biotech powerhouse, JPMorgan says
GlobeAlert Desk · curated from South China Morning Post · East Asia
A lag in foundational research and looming geopolitical risks will weigh on China’s bid to build a world-class biotechnology innovation ecosystem, even as the sector’s overseas momentum remains strong, according to JPMorgan. “In China, there is still some catching up to do in basic research, particularly in biological and pharmaceutical research,” said Yang Huang, head of China healthcare research at JPMorgan, during an interview on Wednesday. To meet the “ambitious goal” set in the country’s...
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
What the desk knows about this story
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Single-source so far. Treat details as unconfirmed until more publishers report.
Not flagged as developing.
- China canada agree to lift more tariffsKidnappings · China · 8h ago
- Vietnam forestry company director shot at officeShootings · Republic Of · 1h ago
- Long March 12 | SatNet LEO Group TBD?Rocket Launches · CHN · now